PolyBio Profile picture
Jul 27 9 tweets 2 min read Read on X
We are excited to have supported this new study via our #LongCovid Research Consortium.  The project team are our incredible @CUBoulderBN colleagues at the University of Colorado Boulder: polybio.org/multiple-hit-m…
Image
2/ The findings suggest that multiple infectious “hits” (#viral and #bacterial) may amplify long-term neuroinflammatory or neuroimmune symptoms in patients with #LongCovid.
3/ More specifically, the team showed that brain exposure to a #SARS-CoV-2 spike protein subunit drove a long-term vulnerability not only to #neuroinflammation, but also to forms of autonomic dysregulation such as increased heart rate and core body temperature.
4/ The research – conducted in rats – also found that S1 protein induced a considerable decrease in cortisol hormone levels in a #brain region called the hippocampus. This process may be related to some teams’ findings of low cortisol #hormone levels in patients with LongCovid.
5/ Neuroimmune ‘priming’ is an effect by which subsequent #immune challenges – such as several infections in a row – can cause increasingly profound and protracted #neuroinflammation,” said PolyBio co-founder and neuroimmunologist Dr. Michael VanElzakker.
6/ This means that multiple inflammatory challenges can add up to be greater than the sum of their parts.
7/ While this group used LPS which is the part of #bacteria that drives inflammation, the phenomenon of priming also relates to other, non-infectious inflammatory challenges such as a concussion.”
8/ The findings suggest that treatment protocols identifying and addressing different #infectious or #inflammatory insults in patients with long COVID or related conditions may be needed to manage symptoms.
9/ They also show that problems like #autonomic dysfunction and #hormonal imbalances in long Covid can be directly connected to #environmental insults and exposures.

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with PolyBio

PolyBio Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @polybioRF

Jul 3
Breaking!: Research published today in Science Translational Medicine and supported by PolyBio Research Foundation shows that the #SARS-CoV-2 virus can chronically persist in the gut of patients with long COVID for over 2 years: polybio.org/chronic-virus-…
2/ The findings, published by a UCSF team known for innovation in HIV research, also documented T cell immune activation across the bodies and brains of people after COVID. This T cell activation was particularly elevated in the spinal cord and gut wall of long COVID participants Image
3/ Long COVID is not a mystery” says UCSF's Michael Peluso MD, who co-led the study. “Our findings provide clear evidence of #virus persistence and sustained immune activation after #COVID-19. We must use this information to test treatments that might get people better.”
Read 13 tweets
May 3
We are proud to have supported this new paper published in @BrainBehavImm.

Led by @MBVanElzakker & team at @MGHMartinos, it is the is first study to document neuroinflammation in the long COVID brain along with evidence of vascular problems: polybio.org/longcovid-brai…
2/ Neuroinflammation was located in some #brain areas that are exposed to circulating blood factors via gaps in the “blood-brain barrier” of the brain’s blood vessels. Image
3/ This compelled the researchers to measure a selection of blood factors related to #vascular health or damage.

They found that six such factors showed a correlation with the neuroinflammation signal in the brains of the long COVID study participants. Image
Read 10 tweets
Apr 11
Great to see this new piece in @ScienceMagazine highlighting LongCovid clinical trials working to target #SARS-CoV-2 persistence. We are proud to be supporting nearly all the teams/trials mentioned in the piece via our LongCovid Research Consortium: science.org/content/articl…
2/ They include the trial at Sinai where @PutrinoLab , @polybio’s Dr. Amy Proal and Akiko Iwasaki’s group at Yale “will study two broad-spectrum antivirals that don’t require viral replication to work: Truvada and Selzentry, both approved for HIV”: polybio.org/projects/a-cli…
@PutrinoLab @polybio 3/ Also the trial in #LongCovid children where @LaelYonker and team are working to determine if Lorazotide can tighten cellular junctions in the #gut lining and stop SARS-CoV-2 spike protein from entering the blood: polybio.org/projects/sars-…
Read 11 tweets
Feb 22
We are excited to announce a 2nd series of collaborative projects & clinical trials supported via our LongCovid Research Consortium: polybio.org/new-longcovid-…
2/ The projects/trials further address #SARS-CoV-2 persistence in #LongCOVID, plus the impact of viral activity on #Alzheimer’s & cardiovascular disease. They include:
1. Icahn School of Medicine Mount Sinai: “A clinical trial of repurposed HIV antivirals in LongCOVID” 👉 Learn more here: polybio.org/projects/a-cli…
Read 23 tweets
Jan 12
PolyBio is glad to have supported this Nature Immunology paper showing #LongCovid immune dysregulation connected to potential #SARS-CoV-2 tissue reservoirs. Learn more about the findings here: polybio.org/polybio-suppor…
2/ Overall, Long COVID patients showed differences in the distributions of their T cells, implying ongoing #immune responses. The team also documented a mis-coordination between the SARS-CoV-2-specific T and B cell responses of Long COVID patients.
3/ What underlies the T and B cell dysfunction identified in the study? Data point to the possibility that persistent #SARS-CoV-2 reservoirs in patient tissue are a contributing factor.
Read 9 tweets
Nov 1, 2023
We are excited to announce a $15M gift from Kanro: a philanthropic fund to support scientific research established by Vitalik Buterin, co-founder of Ethereum: finance.yahoo.com/news/polybio-r…
2/ The funding will support a second phase of research and clinical trials via the #LongCovid Research Consortium (LCRC): a global scientific collaboration to rapidly and openly study core biological drivers of Long COVID: polybio.org/longcovid
3/ This is Buterin's second $15M gift to the Consortium and will allow dozens of new projects to move forward. The focus will be the continued study and treatment of #SARS-CoV-2 persistence as a driver of LongCovid.
Read 18 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us!

:(